lilly
Lilly appoints new chief ethics and compliance officer and senior VP
October 30, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Melissa Barnes, lilly
Eli Lilly has announced that Melissa Barnes will be promoted to chief ethics and compliance officer and senior vice president …
Lilly censured for rep photo
October 25, 2012Medical Communications, Sales and Marketing ABPI, GP, PMCPA, lilly
Lilly has breached the ABPI’s Code of Practice because one of its representatives insisted on taking pictures of doctors underneath …
New drugs for Alzheimer’s trial
October 15, 2012Research and Development, Sales and Marketing Alzheimer's, Roche, lilly
Roche and Eli Lilly are providing drugs free of charge to US investigators conducting a worldwide trial of Alzheimer’s disease …
New possibility for Lilly erectile drug
September 24, 2012Sales and Marketing CHMP, Cialis, ED, hyperplasia, lilly
Eli Lilly’s erectile disfunction (ED) brand Cialis has been recommended to treat benign prostatic hyperplasia (BPH) in Europe. If the …
Online programme to help diabetes patients
September 14, 2012Medical Communications, Sales and Marketing Boehringer, diabetes, lilly
Boehringer Ingelheim and Eli Lilly have launched an online initiative which they say will help diabetes sufferers make simple lifestyle …
Lilly suffers late-stage cancer blow
September 10, 2012Research and Development, Sales and Marketing Alimta, Cancer, avastin, lilly, oncology
Eli Lilly suffered a blow to its oncology programme when a new combination treatment failed to improve overall survival in …
Lilly’s Alzheimer’s drug fails in phase III
August 24, 2012Sales and Marketing Alzheimer's, EXPEDITION, lilly, solanezumab
Lilly has announced that its Alzheimer’s drug candidate solanezumab has failed its primary endpoints in two key phase III trials. …
FDA approves leukaemia drug Marqibo
August 10, 2012Sales and Marketing FDA, Marqibo, Talon Therapeutics, lilly
The Food and Drug Administration has given the green light for Talon Therapeutics’ Marqibo to combat a rare form of …
R&D, East & West: Lilly invests in its global research network
July 10, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Asia, China, R&D, diabetes, lilly
Eli Lilly officially opened its new research facilities at its R&D base in Erl Wood in Surrey in April. The …
Amylin withheld safety data, says FDA
June 27, 2012Research and Development, Sales and Marketing Amylin, Bydureon, Byetta, FDA, lilly
The US medicines regulator says Amylin held back data relating to the safety of its diabetes drug Bydureon. The allegation …
Lilly app aims to boost trial recruitment
June 8, 2012Medical Communications GSK, clinical trials, lilly, oncology
Lilly has launched a new searchable clinical trial mobile app for oncologists. The app is available for the iPad and …
Lechleiter wants policy that spurs innovation
June 8, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Lechleiter, Obama, PhRMA, US, heathcare, lilly
Lilly’s leader is calling on governments to take the long-term view when it comes to healthcare policy. John Lechleiter who …
William Kaelin Jr elected to Lilly board
June 6, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Cancer, Kaelin, lilly
Eli Lilly has elected William Kaelin Jr to its board of directors. Dr Kaelin, 54, is a Professor in the Department of …
Lilly’s John Lechleiter elected as PhRMA Board chairman
April 17, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, John Lechleiter, Pfizer, Sanofi, lilly
John Lechleiter, chairman, president and chief executive of Lilly has been elected chairman of the Pharmaceutical Research and Manufacturers of …
Alzheimer’s diagnostic comes with caveats
April 10, 2012Sales and Marketing Alzheimer's, Amyvid, lilly
A first-in-class test for Alzheimer’s disease has been approved by the FDA, but its makers have stressed its limitations.Lilly’s Amyvid …
Latest content
FibroFind appoints Lee Borthwick as CEO
